International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Response to Weinert
- Boyd E. Metzger, MD1,
- Steven G. Gabbe, MD2,
- Bengt Persson, MD, PHD3,
- Lynn P. Lowe, PHD4,
- Alan R. Dyer, PHD4,
- Jeremy J.N. Oats, MD5 and
- Thomas A. Buchanan, MD6
- 1Division of Endocrinology, Northwestern University Feinberg School of Medicine, Chicago, Illinois;
- 2Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio;
- 3Department of Pediatrics, Karolinska Institute, Stockholm, Sweden;
- 4Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois;
- 5Department of Obstetrics and Gynaecology, University of Melbourne, Burnley, Victoria, Australia;
- 6Division of Endocrinology and Diabetes, University of Southern California Keck School of Medicine, Los Angeles, California.
- Corresponding author: Boyd E. Metzger, bem{at}northwestern.edu.
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort.
The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some …
In this Issue
July 2010, 33(7)
International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
